Get the technology you need today to stay competitive tomorrow.

With Illumina Capital, you can acquire the advanced technology you need now through fast, easy, and affordable financing and leasing programs. When you finance, you can:

• Keep pace with rapid advancements: Acquire or upgrade to new equipment right away.
• Preserve valuable lines of credit: Leave your lines of credit open to meet future business needs, grow your facility, or fund other operating expenses.
• Overcome capital budget constraints: Pay for the equipment over time using your operating budget, so you don’t have to wait for capital budget funding.

Financing Options

• 100% financing of reagents and equipment with flexible structuring.
• Reagent Rental program
• Ability to upgrade/add technology during the lease term.
• Payment plan choices to align with your cash flow cycle, reimbursement funding cycle, or projected use.
• Terms ranging from 12–60 months with flexible end-of-term options.

 

 

 

 

To explore your financial options, please call your Illumina sales representative.

 

800.809.4566 (North America)
858.202.4566 (Outside)

Hours: 7:00 a.m.–5:00 p.m. (PT)

Illumina Capital is a program of De Lage Landen Financial Services, a worldwide leader in equipment leasing and financing solutions.

 

Innovative technologies

At Illumina, our goal is to apply innovative sequencing and array technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service.
As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative sequencing and array-based solutions for genomic analysis serve as tools for disease research, drug discovery, and the development of molecular tests in clinical labs.

Leading-edge products and services

Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine. Our offering includes leading-edge solutions for:
SNP genotyping
Copy number variation
Genome sequencing
DNA methylation studies
Transcriptome analysis
Gene expression profiling
Our products and services are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.